| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/17/2007 | EP0687272B1 Method and compositions for recombinant osteogenic protein production |
| 01/17/2007 | CN1898262A Il-7 fusion proteins |
| 01/17/2007 | CN1897969A Selective incorporation of 5-hyroxytrypophan into proteins in mammalian cells |
| 01/17/2007 | CN1896268A Extraction of activated micromolecular sheept germine from sheep embryo and its use |
| 01/17/2007 | CN1896267A Preparation of depressor peptide by silkworm chrysalis |
| 01/17/2007 | CN1896266A Preparation of bioactive peptide for inhibiting meat fat oxidation |
| 01/17/2007 | CN1896265A Production of natural-silk nutrient and silk polypeptide by enzyme method |
| 01/17/2007 | CN1896262A Technology of animal high-calcium powder, chondrine and collagen by composite enzyme method |
| 01/17/2007 | CN1896261A Production of rice-starch and rice-protein polypeptide powder by composite enzyme method |
| 01/17/2007 | CN1896247A Fibroblast-like cell specific non-viral carrier, its construction and use |
| 01/17/2007 | CN1896245A Production of gene recombinant fusion protein K1-EN |
| 01/17/2007 | CN1896241A Enteromycin C2 total gene, its clone and heterologous expression |
| 01/17/2007 | CN1896106A Preparation of human plasma protein fused long-effective interferon |
| 01/17/2007 | CN1896104A Fused protein for cell inhibitory factor and albumin |
| 01/17/2007 | CN1895670A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases |
| 01/17/2007 | CN1295511C Detection for zearalenone |
| 01/17/2007 | CN1295510C Methods using 06-alkylguanine-DNA alkyltransferase |
| 01/17/2007 | CN1295331C Oncogene, recombinant protein derived therefrom, and uses thereof |
| 01/16/2007 | US7164012 Nucleic acids, expression vectors and host cells exhibiting the same peptidyl-prolyl isomerase activity as a Pin protein fragment; antimitotic agents |
| 01/16/2007 | US7164009 Pro9821 polypeptides |
| 01/16/2007 | US7164007 Antitumor agents; anticancer agents; wound healing agents; cardiovascular disorders |
| 01/16/2007 | US7164001 Compositions and methods for the treatment of immune related diseases |
| 01/16/2007 | US7164000 RANTES mutants and therapeutic applications thereof |
| 01/16/2007 | US7163824 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 01/16/2007 | US7163819 Bacterial hemoglobin genes and their use to increase carotenoid production |
| 01/16/2007 | US7163817 Clot-specific streptokinase proteins possessing altered plasminogen activation characteristics and a process for their preparation |
| 01/16/2007 | US7163814 Modified reductase and its gene, and use thereof |
| 01/16/2007 | US7163808 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family |
| 01/16/2007 | US7163806 mammalian therapeutics free from prion contamination |
| 01/16/2007 | US7163805 Human serum albumin-TIMP2 fusion protein, a polynucleotide encoding the same and a method of producing the human serum albumin-TIMP2 fusion protein |
| 01/16/2007 | US7163804 Non-toxic non-toxigenic non-pathogenic fusarium expression system |
| 01/16/2007 | US7163798 Method of preparing cow brain homogenate |
| 01/16/2007 | US7163797 50 human secreted proteins |
| 01/16/2007 | US7163793 Preparing immunoglobulins for use as tools in prevention of DNA and RNA degradation during molecular analysis; enzyme inhibitors |
| 01/16/2007 | US7163681 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma |
| 01/16/2007 | US7163680 Contacting vascular endothelial cells proximate to cancerous cells with the biological agent to permit both binding of biological agent to vascular endothelial cells proximate to cancerous cells and ablating or killing of cancerous cells |
| 01/16/2007 | CA2103996C Dimer of molecular variant of apolipoprotein and processes for the production thereof |
| 01/11/2007 | WO2007005955A2 Anti-il-23 antibodies, compositions, methods and uses |
| 01/11/2007 | WO2007005918A2 Production of cellulase |
| 01/11/2007 | WO2007005612A2 An integrated approach for generating multidomain protein therapeutics |
| 01/11/2007 | WO2007005596A2 Production of cpd glycosylases |
| 01/11/2007 | WO2007004876A2 Peptides inhibiting angiotensin-converting enzyme |
| 01/11/2007 | WO2007004654A1 Mutant pcna |
| 01/11/2007 | WO2007004538A1 Method for production of recombinant protein |
| 01/11/2007 | WO2007004325A1 Protein preparation containing s1-5 |
| 01/11/2007 | WO2007003582A2 Serum-free stable transfection and production of recombinant human proteins in human cell lines |
| 01/11/2007 | WO2007003410A1 Use of lepa for improving the accuracy of protein synthesis in vitro |
| 01/11/2007 | WO2007003041A1 Methods of isolating cells and generating monoclonal antibodies |
| 01/11/2007 | WO2006096710A3 Detection, imaging, and depletion of chlamydia |
| 01/11/2007 | WO2006086012A3 Antibiotic compound |
| 01/11/2007 | WO2006031993A3 Enhancing recombinant hemoglobin production by co-expression with alpha hemoglobin stabilizing protein |
| 01/11/2007 | WO2005124358A3 Diagnosis and treatment of siglec-6 associated diseases |
| 01/11/2007 | WO2005116200A3 Nucleic acids and polypeptides involved in the production of cryptophycin |
| 01/11/2007 | US20070011760 Nucleic acids that control seed and fruit development in plants |
| 01/11/2007 | US20070010662 VGF fusion polypeptides |
| 01/11/2007 | US20070010661 Chromatography separation using apatite; protein being purified can comprise at least one constant antibody immunoglobulin domain |
| 01/11/2007 | US20070010658 Trimeric binding proteins for trimeric cytokines |
| 01/11/2007 | US20070010657 Cytoplasmic dynein heavy chain 1 genes, expression products, non-human animal model uses in human neurological diseases |
| 01/11/2007 | US20070010444 Novel mediator of neurotransmitter and psychostimulant responses |
| 01/11/2007 | US20070010442 Inhibitor of vascular endothelial cell growth factor |
| 01/11/2007 | US20070010434 Novel compositions and methods for the treatment of immune related diseases |
| 01/11/2007 | US20070010432 Heat shock protein 90 activator |
| 01/11/2007 | US20070010418 For use in detergent, flour for producing a dough or a baked product |
| 01/11/2007 | US20070010417 Novel alkaline protease and washing and cleaning products containing said novel alkaline protease |
| 01/11/2007 | US20070010416 Protease with improved stability in detergents |
| 01/11/2007 | US20070010030 Complement C3 precursor biopolymer markers indicative of insulin resistance |
| 01/11/2007 | US20070010029 Protein biopolymer markers predictive of insulin resistance |
| 01/11/2007 | US20070010000 Protein of given sequence; improved action and substrate specificity; use in diagnosis kits |
| 01/11/2007 | US20070009996 Ginkgo biloba levopimaradiene synthase |
| 01/11/2007 | US20070009995 Prevention of incorporation of non-standard amino acids into protein |
| 01/11/2007 | US20070009994 Antigenic polypeptide SE36 of malaria plasmodium, process for purification thereof, and vaccine and diagnostic agent using the antigen |
| 01/11/2007 | US20070009992 Purified mutant DNA comprising a TLR4 human genomic segment; identifying polymorphisms; expression cassettes; nucleic acid molecule of operably linked to a promoter, so that host cell expresses variant TLR4; diagnosing susceptibility to asthma, respiratory system disorders, arthritis, cystic fibrosis |
| 01/11/2007 | US20070009991 Gene expression in transgenic avians |
| 01/11/2007 | US20070009990 Site-specific incorporation of redox active amino acids into proteins |
| 01/11/2007 | US20070009989 Synthetic heparanase molecules and uses thereof |
| 01/11/2007 | US20070009988 Leucine aminopeptidase polypeptide, carboxypeptidases polypeptide; dermatophyte; degradation, hydrolysis or maturation of polypeptide substrate; Exonuclease X of Escherichia coli ( EXOX protein); fungicides; dipeptidyl peptidase IV |
| 01/11/2007 | US20070009987 recombinant fusion protein comprising binding domain antibody that binds to cell-surface antigen, functional group domain for eliciting desired effect on target molecule, extension peptide between binding domain and functional group domain containing uncoupled cysteine residue capable of forming s-s bond |
| 01/11/2007 | US20070009986 Compositions for modulating immune cell activity and methods for detection thereof |
| 01/11/2007 | US20070009985 Novel nitrile hydratase |
| 01/11/2007 | US20070009981 Nematode phosphoethanolamine N-methyltransferase-like sequences |
| 01/11/2007 | US20070009979 Cyclic GMP dependent protein kinase as a chemotherapeutic target for antiprotozoal agents |
| 01/11/2007 | US20070009975 incubating a sample from humans with monoclonal antibodies or fragments, that specifically binds epitopes of campylobacter antigens, then detecting the formation of antigen-antibody complexes which is indicative of an infection of campylobacter |
| 01/11/2007 | US20070009972 Epidermal growth factor receptor polypeptides and antibodies |
| 01/11/2007 | US20070009971 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 01/11/2007 | US20070009964 competing with natural OX40L for blocking OX40R-mediated cell signaling in the prophylaxis and/or treatment of diseases related to activated T cells |
| 01/11/2007 | US20070009963 Apolipoprotein biopolymer marker indicative of normal human |
| 01/11/2007 | US20070009962 Nucleic acid binding polypeptide library |
| 01/11/2007 | US20070009959 Methods for producing antibodies |
| 01/11/2007 | US20070009957 Vectors used to create hybrid constant regions |
| 01/11/2007 | US20070009955 Secreted polypeptide species associated with cardiovascular disorders |
| 01/11/2007 | US20070009953 Using capsid specific primer sequences to screen for and detect low concentrations of flaviviruses |
| 01/11/2007 | US20070009952 detecting susceptibility for basement membrane disease such as congenital nephrotic syndromes of the Finnish type (NPHS1); proteinuria; detecting the presence or absence of a mutation in the coding region of the gene for NPHS1 |
| 01/11/2007 | US20070009951 Gene expression vaccine |
| 01/11/2007 | US20070009950 Methods and compositions for vitamin K epoxide reductase |
| 01/11/2007 | US20070009948 Nucleic acid binding polypeptide library |
| 01/11/2007 | US20070009945 Endothelins; renin; kits |
| 01/11/2007 | US20070009942 Methods and compositions for evolving hydrogenase genes |
| 01/11/2007 | US20070009941 Complementary DNAs |
| 01/11/2007 | US20070009936 mTOR kinase-associated proteins |
| 01/11/2007 | US20070009933 PGC-1beta, a novel PGC-1 homologue and uses therefor |